REN and Hypertension: The coexistence of hypertension with glucose and lipid metabolic disorders may generate synergistic effects that exacerbate IR, activate the renin-angiotensin-aldosterone system and sympathetic nervous system, and subsequently lead to structural and functional deterioration of the heart (61, 62), thereby worsening clinical outcomes in ADHF patients.